8-K: Willis Towers Watson Reports Strong Q3 2024 Results Despite TRANZACT Impairment

Willis Towers Watson (WTW) announced a 6% increase in revenue and a 31% rise in adjusted diluted earnings per share for the third quarter of 2024, despite a significant loss due to the pending sale of TRANZACT.

Summary

• Willis Towers Watson (WTW) reported a 6% increase in revenue to $2.3 billion for the third quarter of 2024, with organic growth also at 6%.
• The company experienced a diluted loss per share of $16.44, primarily due to pre-tax non-cash losses and impairment charges exceeding $1.0 billion related to the pending sale of TRANZACT.
• Adjusted diluted earnings per share were $2.93, a 31% increase compared to the prior year.
• Adjusted operating margin was 18.1%, up 190 basis points from the previous year.
• The Health, Wealth & Career (HWC) segment saw a 4% organic revenue growth, while the Risk & Broking (R&B) segment achieved a 10% organic revenue growth.
• Free cash flow for the nine months ended September 30, 2024, was $807 million, an increase of $100 million year-over-year.
• WTW repurchased $205 million of its outstanding shares during the quarter.
• The company is targeting full-year 2024 revenue of $9.9 billion or greater, with mid-single-digit organic revenue growth.
• WTW expects an adjusted operating margin of 23.0% 23.5% and adjusted diluted earnings per share of $16.00 $17.00 for the full year 2024.
• The Transformation program is expected to deliver approximately $450 million in cumulative run-rate savings by the end of 2024, with total program costs of $1.175 billion.

Sentiment

Score: 6

Explanation: The sentiment is mixed. While the company shows strong revenue growth and improved adjusted earnings, the significant loss due to the TRANZACT sale and negative operating margin temper the overall positive outlook. The company's forward guidance is positive, but the current results are impacted by the divestiture.

Positives

• Revenue increased by 6% year-over-year, demonstrating strong market demand.
• Adjusted diluted earnings per share grew by 31%, indicating improved profitability.
• The adjusted operating margin expanded by 190 basis points, reflecting enhanced operational efficiency.
• Free cash flow increased by $100 million year-over-year, showcasing improved cash generation.
• The company is making significant progress on its Transformation program, with $446 million in annualized savings achieved.
• Both the Health, Wealth & Career and Risk & Broking segments showed positive organic revenue growth.
• WTW is actively returning capital to shareholders through share repurchases and dividends.
• The company is confident in achieving its full-year 2024 financial targets.

Negatives

• The company reported a significant net loss of $1.67 billion for the quarter, primarily due to non-cash losses and impairment charges related to the pending sale of TRANZACT.
• Diluted loss per share was $16.44, significantly impacted by the TRANZACT sale.
• The operating margin was negative at (33.5)% due to the TRANZACT related losses.
• The Benefits Delivery & Outsourcing (BD&O) segment experienced an organic revenue decline for the quarter.

Risks

• The pending sale of TRANZACT has resulted in significant non-cash losses and impairment charges, impacting the company's reported earnings.
• The company faces risks related to the successful execution of its global business strategy and the realization of anticipated benefits from acquisitions and divestitures.
• Macroeconomic trends, including inflation, changes in interest rates, and trade policies, could adversely affect the company's financial performance.
• The company is exposed to risks related to cybersecurity breaches, data privacy, and compliance with evolving regulations.
• Fluctuations in foreign currency rates could impact the company's financial results.
• The company faces competition and the potential for loss of market share.
• There are risks associated with the company's multi-year operational transformation program, including the ability to achieve cost savings and manage organizational changes.
• The company is subject to various claims, government inquiries, and investigations, which could result in negative outcomes.

Future Outlook

WTW expects to deliver revenue of $9.9 billion or greater, mid-single-digit organic revenue growth, an adjusted operating margin of 23.0% 23.5%, and adjusted diluted earnings per share of $16.00 $17.00 for the full year 2024. The company also anticipates approximately $450 million in cumulative run-rate savings from the Transformation program by the end of 2024.

Management Comments

• We had another strong quarter fueled by revenue growth, operating leverage and the success of our Transformation program.
• Our revenue growth of 6% for the quarter is evidence that our value proposition is continuing to resonate in the market and that our investments in talent and technology are succeeding.
• We are also making ongoing progress on our commitment to improve cash flow.
• Given our strong performance and momentum, we are entering the fourth quarter with confidence in our ability to deliver on our targets for the year and drive sustainable, profitable growth going forward.

Industry Context

The results reflect a mixed performance in the advisory, broking, and solutions industry, with strong revenue growth offset by significant losses from a divestiture. The company's focus on transformation and cost savings aligns with industry trends towards operational efficiency and profitability.

Comparison to Industry Standards

• WTW's 6% organic revenue growth is solid compared to peers in the insurance and consulting industry, though specific competitor results would be needed for a more precise comparison.
• The adjusted operating margin of 18.1% is competitive, but the GAAP operating margin is significantly impacted by the TRANZACT sale.
• Companies like Aon and Marsh McLennan, which are major competitors, also focus on organic growth and margin expansion, but their specific results vary based on their business mix and strategic initiatives.
• The $446 million in annualized savings from the Transformation program is a significant achievement, comparable to cost-cutting initiatives seen in other large consulting and brokerage firms.
• The free cash flow increase of $100 million year-over-year is a positive sign, but the overall cash flow performance needs to be compared to industry benchmarks to assess its relative strength.

Stakeholder Impact

• Shareholders will be impacted by the significant net loss and diluted loss per share, but may be encouraged by the strong revenue growth and improved adjusted earnings.
• Employees may be affected by the ongoing Transformation program and organizational changes.
• Customers should benefit from the company's continued investments in talent and technology.
• Suppliers and creditors will be impacted by the company's financial performance and capital allocation decisions.

Next Steps

• The company will host an Investor Day on December 3, 2024.
• WTW will continue to execute its Transformation program to achieve cost savings and improve operational efficiency.
• The company will focus on delivering its 2024 financial targets.
• WTW will continue to monitor market conditions and adjust its strategies as needed.

Key Dates

Keywords

financial results, revenue growth, earnings per share, operating margin, organic growth, free cash flow, share repurchases, transformation program, TRANZACT, Health, Wealth & Career, Risk & Broking